Suppr超能文献

氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在调查疑似肝细胞癌复发患者不明原因血清甲胎蛋白升高方面的应用。

Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.

作者信息

Chen Yen-Kung, Hsieh Dar-Shih, Liao Chao-Sheng, Bai Chyi-Huey, Su Chen-Tau, Shen Yeh-You, Hsieh Jih-Fang, Liao Alfred C, Kao Chia-Hung

机构信息

Department of Nuclear Medicine and PET Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei and China Medical University, Taichung, Taiwan.

出版信息

Anticancer Res. 2005 Nov-Dec;25(6C):4719-25.

Abstract

UNLABELLED

The aim of this study was to evaluate the potential role of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unexplained rising serum alpha-fetoprotein (AFP) levels after the treatment of hepatocellular carcinoma (HCC).

PATIENTS AND METHODS

Thirty-one FDG-PET studies were performed in 26 patients (age range, 45-83; 21 men and 5 women), who had undergone either surgical resection or interventional therapy for HCC, but were subsequently noted to have high AFP serum levels on routine follow-up examinations, although imaging studies and physical examinations were normal. The FDG-PET results were correlated with histological findings, as well as long-term radiological and clinical follow-up (shortest follow-up period after FDG-PET was 6 months).

RESULTS

FDG-PET was abnormal in 22 of the 31 studies (71.0%) among the 26 patients. Intrahepatic lesions were detected in 20 of a total 30 lesions (66.7%) in 18 studies of FDG-PET among 26 patients. Ten FDG-PET studies among 9 patients identified one intrahepatic lesion, while 3 studies among 3 patients identified more than one intrahepatic lesion. Extrahepatic metastases were found in 9/31 studies of FDG-PET (29.0%) among 8 patients. These metastatic foci, composed of increased FDG accumulation, were identified in several locations; lung (4 studies among 4 patients), bone (2 studies among 2 patients) and the peritoneum (4 studies among 3 patients). Overall, FDG-PET for detecting HCC recurrence demonstrated 22 true-positives, 8 false-negatives, 1 true-negative and 0 false-positive results., The sensitivity, specificity and accuracy of FDG-PET for detecting HCC recurrence was 73.3%, 100% and 74.2%, respectively.

CONCLUSION

When conventional examinations are normal, FDG-PET is a valuable imaging tool in patients who have rising AFP levels after HCC treatment. FDG-PET whole-body scan also provides an important and valuable imaging study for detecting extrahepatic metastasis.

摘要

未标记

本研究的目的是评估18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)在肝细胞癌(HCC)治疗后血清甲胎蛋白(AFP)水平不明原因升高患者中的潜在作用。

患者与方法

对26例患者(年龄范围45 - 83岁;男性21例,女性5例)进行了31次FDG-PET检查,这些患者均接受过HCC手术切除或介入治疗,但在常规随访检查中发现AFP血清水平升高,尽管影像学检查和体格检查均正常。将FDG-PET结果与组织学结果以及长期影像学和临床随访(FDG-PET后最短随访期为6个月)进行关联分析。

结果

26例患者的31次检查中有22次(71.0%)FDG-PET结果异常。在26例患者的18次FDG-PET检查中的30个病变中,有20个(66.7%)检测到肝内病变。9例患者的10次FDG-PET检查发现1个肝内病变,3例患者的3次检查发现多个肝内病变。8例患者的31次FDG-PET检查中有9次(29.0%)发现肝外转移。这些转移灶表现为FDG摄取增加,见于多个部位;肺(4例患者中的4次检查)、骨(2例患者中的2次检查)和腹膜(3例患者中的4次检查)。总体而言,用于检测HCC复发的FDG-PET显示22个真阳性、8个假阴性、1个真阴性和0个假阳性结果。FDG-PET检测HCC复发的敏感性、特异性和准确性分别为73.3%、100%和74.2%。

结论

当常规检查正常时,FDG-PET对于HCC治疗后AFP水平升高的患者是一种有价值的影像学工具。FDG-PET全身扫描对于检测肝外转移也提供了一项重要且有价值的影像学检查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验